ADVIA Centaur High-Sensitivity Troponin I (TNIH)
Immunoassay Method, Troponin Subunit. 510(k) K171274, from Siemens Healthcare Diagnostics, Inc. (Tarrytown, NY). Product code MMI, class 2.
As of Nov 20, 2026, K171274 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Jul 12, 2018 after 437 days, with no recalls tied to it in FDA's recall database.
- Review time: 437 days
- Recalls: 0
The ADVIA Centaur High-Sensitivity Troponin I (TNIH) assay is for in vitro diagnostic use in the quantitative measurement of cardiac troponin I in human serum or plasma (lithium heparin) using the ADVIA Centaur XP system. The assay can be used to aid in the diagnosis of acute myocardial infarction (AMI).
- Elecsys Troponin T Gen 5 STAT Assay, Elecsys Troponin T Gen 5 STAT CalSet, Elecsys PreciControl Troponin, Elecsys…K162895 · Roche Diagnostics · Jan 18, 2017
- i-STAT hs-TnI cartridge with the i-STAT Alinity SystemK253051 · Abbott Point of Care, Inc. · Jun 11, 2026
- VITROS Immunodiagnostic Products hs Troponin I Reagent PackK252393 · Ortho-Clinical Diagnostics, Inc. · Oct 29, 2025
- Access hsTnIK243483 · Beckman Coulter, Inc. · Aug 1, 2025
- Access hsTnIK242870 · Beckman Coulter, Inc. · Jun 16, 2025
- i-STAT hs-TnI cartridge with the i-STAT 1 SystemK240984 · Abbott Point of Care, Inc. · Jan 3, 2025
- Atellica® IM High-Sensitivity Troponin I (TnIH)K241165 · Siemens Healthcare Diagnostics, Inc. · Jul 25, 2024
- PATHFAST®hs-cTnI-IIK231974 · Phc Corporation · Mar 20, 2024
- Access hsTnIK222881 · Beckman Coulter, Inc. · Dec 18, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 1, 2017
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1215
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files